California’s life science industry is a major economic driver for the state. It generates over 1 million jobs, continuously provides new innovations in health and has led the nation in NIH funding and venture capital for years. But the picture isn’t all rosy for the industry and pressures on today’s California life sciences companies, entrepreneurs and executive teams continue to mount.
The industry has long managed regulation uncertainties but increasing challenges with reimbursement, pricing pressures and how to navigate healthcare reform are building. The IPO window has improved the funding environment, but CEOs are still forced to build companies without clearly defined exits. And while they are constantly tweaking their R&D and innovation strategies, a major challenge for CEOs today is how to turn their discoveries into commercial realities.
To discuss how CEOs and entrepreneurs perceive and manage risk within the turbulent life science industry, CALBIO2015 offers a platform for industry leaders in California to share ideas ranging from science to business to global issues.
A joint BayBio and Biocom event, CALBIO2015 Conference provides an opportunity for a frank and thoughtful discussion on how to turn today’s challenges into tomorrow’s opportunities. The two-day statewide industry event attracts the world’s leading life science and pharmaceutical companies, investment funds, patient foundations and university technology transfer offices.
March 2-3, 2015
San Francisco Marriott Marquis
|Click Here to Register|